288 related articles for article (PubMed ID: 33114380)
41. Hepatocyte growth factor improves bone regeneration via the bone morphogenetic protein‑2‑mediated NF‑κB signaling pathway.
Zhen R; Yang J; Wang Y; Li Y; Chen B; Song Y; Ma G; Yang B
Mol Med Rep; 2018 Apr; 17(4):6045-6053. PubMed ID: 29436622
[TBL] [Abstract][Full Text] [Related]
42. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
43. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
[TBL] [Abstract][Full Text] [Related]
44. Abietic acid attenuates RANKL induced osteoclastogenesis and inflammation associated osteolysis by inhibiting the NF-KB and MAPK signaling.
Thummuri D; Guntuku L; Challa VS; Ramavat RN; Naidu VGM
J Cell Physiol; 2018 Jan; 234(1):443-453. PubMed ID: 29932225
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory activity of linarin on osteoclastogenesis through receptor activator of nuclear factor κB ligand-induced NF-κB pathway.
Wang J; Fu B; Lu F; Hu X; Tang J; Huang L
Biochem Biophys Res Commun; 2018 Jan; 495(3):2133-2138. PubMed ID: 29269297
[TBL] [Abstract][Full Text] [Related]
46. A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts.
Ikawa Y; Yonekawa T; Ohkuni Y; Kuribayashi M; Fukino K; Ueno K
J Toxicol Sci; 2007 Dec; 32(5):555-64. PubMed ID: 18198485
[TBL] [Abstract][Full Text] [Related]
47. Pim-1 regulates RANKL-induced osteoclastogenesis via NF-κB activation and NFATc1 induction.
Kim K; Kim JH; Youn BU; Jin HM; Kim N
J Immunol; 2010 Dec; 185(12):7460-6. PubMed ID: 21068407
[TBL] [Abstract][Full Text] [Related]
48. The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expression.
Roux S; Mariette X
Leuk Lymphoma; 2004 Jun; 45(6):1111-8. PubMed ID: 15359989
[TBL] [Abstract][Full Text] [Related]
49. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
[TBL] [Abstract][Full Text] [Related]
50. BMAL1 regulates balance of osteogenic-osteoclastic function of bone marrow mesenchymal stem cells in type 2 diabetes mellitus through the NF-κB pathway.
Li X; Liu N; Gu B; Hu W; Li Y; Guo B; Zhang D
Mol Biol Rep; 2018 Dec; 45(6):1691-1704. PubMed ID: 30259246
[TBL] [Abstract][Full Text] [Related]
51. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
[TBL] [Abstract][Full Text] [Related]
52. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
53. DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.
Sundaram K; Mani SK; Kitatani K; Wu K; Pestell RG; Reddy SV
J Cell Biochem; 2008 Apr; 103(6):1747-59. PubMed ID: 17891780
[TBL] [Abstract][Full Text] [Related]
54. Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway.
Ahn KS; Sethi G; Chaturvedi MM; Aggarwal BB
Int J Cancer; 2008 Oct; 123(8):1733-40. PubMed ID: 18688862
[TBL] [Abstract][Full Text] [Related]
55. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling.
Kim JY; Kim JY; Kim JJ; Oh J; Kim YC; Lee MS
Biol Pharm Bull; 2014; 37(2):255-61. PubMed ID: 24492722
[TBL] [Abstract][Full Text] [Related]
56. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
[TBL] [Abstract][Full Text] [Related]
57. Alpha1-adrenergic receptor stimulation induces the expression of receptor activator of nuclear factor kappaB ligand gene via protein kinase C and extracellular signal-regulated kinase pathways in MC3T3-E1 osteoblast-like cells.
Nishiura T; Abe K
Arch Oral Biol; 2007 Aug; 52(8):778-85. PubMed ID: 17306214
[TBL] [Abstract][Full Text] [Related]
58. Longan fruit increase bone mineral density in zebrafish and ovariectomized rat by suppressing RANKL-induced osteoclast differentiation.
Son Y; Lee EM; Lee DY; Lee JH; Oh S
Phytomedicine; 2019 Jun; 59():152910. PubMed ID: 30978650
[TBL] [Abstract][Full Text] [Related]
59. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
60. IL-3 Differentially Regulates Membrane and Soluble RANKL in Osteoblasts through Metalloproteases and the JAK2/STAT5 Pathway and Improves the RANKL/OPG Ratio in Adult Mice.
Singh K; Piprode V; Mhaske ST; Barhanpurkar-Naik A; Wani MR
J Immunol; 2018 Jan; 200(2):595-606. PubMed ID: 29203513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
